Abstract:Purpose: Osteoarthritis (OA) is a multifactorial disease characterized by loss of articular cartilage. TGFβ is considered as a protective factor against cartilage loss in young cartilage by inducing Smad2/3 phosphorylation via the TGFβ receptor ALK5. Smad2/3 phosphorylation (Smad2/3P) lowers MMP13 expression, and prevents deleterious terminal differentiation of chondrocytes. In contrast to Smad2/3P, Smad1/5 phosphorylation, induced by BMPs but also by TGFβ, is linked to terminal differentiation and MMP13 production. Type I receptors that phosphorylate Smad1/5/8 include ALK1 and ALK3. BMP-9 signals via ALK1 and BMP-2 via ALK3, and both ligands induce enhanced glycosaminoglycan synthesis in young cartilage. BMP2 is induced in damaged cartilage while BMP9 is constitutively present in high concentrations in body fluids. If and how these factors modulate chondroprotective TGFβ signaling is still unclear. Therefore, we analyzed BMP-2 and BMP-9 induced Smad signaling and gene expression in chondrocytes, and studied their interaction with TGFβ. Methods: Primary bovine chondrocytes, isolated from the metacarpophalangeal joint of 2 year old animals, or the human G6 chondrocyte cell line were cultured to near confluency and incubated with TGFβ1, BMP-2, BMP-9 or a combination thereof. Smad phosphorylation kinetics were analyzed by specific Smad2p and Smad1/5p staining of Western blots. Expression patterns of Smad specific response genes: PAI-1 (Smad3 signaling), and ID-1, (Smad1/5 signaling) were analyzed from 0-48h by quantitative real time PCR (qPCR). Biological activity was tested with a CAGA12-luc transcriptional reporter construct that produces luciferase in response to Smad3 signaling. Adenovirally transduced cells (MOI = 5) were serum starved for 8h, and stimulated with growth factors for 20h, and luciferase activity was measured. Results: In primary chondrocytes, both BMP-2 and BMP-9 potently induced Smad1/5 phosphorylation, which peeked after 1 h and lasted up to 3 h. BMP-9 was more potent than BMP-2 in inducing Smad1/5p, as a lower dose of BMP-9 (5 ng/ml BMP-9 versus 15 ng/ml BMP-2) was required to induce maximal phosphorylation after 60 min. Remarkably BMP-9 (5 ng/ml or more) was also capable of inducing Smad2 phosphorylation, whereas BMP-2 (up to 50 ng/ml) was not. BMP-9-induced Smad2 phosphorylation lasted from 1 up to 3 hours. Moreover, in contrast to BMP-2, BMP-9 was also able to rapidly (from 2 up to 24h) induce PAI-1 transcription. Both growth factors potently induced ID-1 expression. Strikingly, co-stimulation of primary chondrocytes with TGFβ (1 ng/ml) and these BMPs revealed an even more remarkable difference between both factors on Western blot. BMP-2 was able to dose-dependently (15-50 ng/ml) inhibit TGFβ-induced Smad2 phosphorylation. On the contrary, BMP-9 dose-dependently (5-25 ng/ml) synergized with TGFβ on Smad2/3 phosphorylation. These results were reflected in biological activity, as luciferase production was increased by 50% after co-stimulation of chondrocytes with BMP-9 and TGFβ compared to TGFβ alone (p<0.01). Conclusions: In young cartilage, both BMPs show a distinct difference in Smad phosphorylation and interaction with TGFβ. Although both BMPs promote matrix synthesis (Glycosaminoglycans production), long term effects of both factors on cartilage will most likely differ due to their different effects on chondroprotective Smad2/3 signaling.

Transforming growth factor-beta1 supports the rapid morphogenesis of heterotopic endochondral bone initiated by human osteogenic protein-1 via the synergistic upregulation of molecular markers

The Effect of Rhbmp-2 on Canine Osteoblasts Seeded Onto 3d Bioactive Polycaprolactone Scaffolds

Synergism of rhBMP-2 and TGF-β in osteoinduction and osteogenesis

Local application of rhTGF-beta2 modulates dynamic gene expression in a rat implant model

Synergism of rhBMP-2, TGF-β and bFGF in osteoindution and osteogenesis

A Recombinant Human TGF-β1 Fusion Protein with Collagen-Binding Domain Promotes Migration, Growth, and Differentiation of Bone Marrow Mesenchymal Cells

EXPRESSION OF NERVE GROWTH FACTOR AND ITS RECEPTOR DURING OSTEOINDUCTION OF RECOMBINED HUMAN BONE MORPHOGENETIC PROTEIN 2

2:20 the Osteogenic Activity of 14 Types of Bone Morphogenic Proteins

Synergistic Effect of Nerve Growth Factor on Ectopic Bone Formation Induced by Recombinant Human Bone Morphogenetic Protein-2

Expression of neurotrophic factors and their receptors during osteoinduction of recombined human bone morphogenetic protein-2

Recombinant human transforming growth factor β1 modulates bone remodeling in a mineralizing bone organ culture

Collagen-targeted BMP3 fusion proteins arrayed on collagen matrices or porous ceramics impregnated with Type I collagen enhance osteogenesis in a rat cranial defect model.

Differential Effects of Bone Morphogenetic Protein 2 and 9 On Chondroprotective Transforming Growth Factor beta Signaling

Inhibitory Effects of Combined Bone Morphogenetic Protein 2, Vascular Endothelial Growth Factor, and Basic Fibroblast Growth Factor on Osteoclast Differentiation and Activity

Osteogenic Responses to Different Concentrations/Ratios of BMP-2 and Bfgf in Bone Formation

Differential effects of osteogenic protein-1 (BMP-7) on gene expression of BMP and GDF family members during differentiation of the mouse MC615 chondrocyte cells

Synergistic Effect of RhBMP-2 and Bfgf on Ectopic Osteogenesis in Mice.

Biphasic effects of transforming growth factor β on bone morphogenetic protein-induced osteoblast differentiation

Growth Hormone Synergizes with BMP9 in Osteogenic Differentiation by Activating the JAK/STAT/IGF1 Pathway in Murine Multilineage Cells.

Cartilage-derived morphogenetic proteins and osteogenic protein-1 differentially regulate osteogenesis.

Recombinant human bone morphogenic protein-2 in tissue engineering and gene therapy